Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DREPAMASSE Study - Evaluation of a Newborn Screening for Sickle Cell Disease by Tandem Mass Spectrometry

NCT03985501 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

NCT NCT03985501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03985501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DREPAMASSE Study - Evaluation of a Newborn Screening for Sickle Cell Disease by Tandem Mass Spectrometry
Lead sponsor
Hospices Civils de Lyon
Phase
Observational
Overall status
Completed
Start date
March 16, 2021
Completion date
December 10, 2022
Enrollment
1,431 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

drepanocytosis, infant, newborn, disease, sickle cell disease